Browse by popular tags
abvd ac220 act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy alemtuzumab all allogeneic allogeneic stem cell transplant amgen aml aml 17 angioimmunoblastic lymphoma antiviral therapy arctic aspirin autologous stem cell transplant autologous transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia bexarotene blood cancers blood transfusions bone marrow
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
A multicentre, randomized, doubleblind, placebo controlled clinical trial of deferasirox in patients with myelodysplastic syndromes (low/int-1 risk) and transfusional iron overload.
Novartis Exjade/Deferasirox Cardiac Iron A2206
A multicenter, randomized, open-label phase II trial evaluating deferasirox compared with deferoxamine in
patients with cardiac iron overload due to chronic blood transfusions